Higher incidence of acute kidney injury in patients treated with piperacillin/tazobactam than in patients treated with cefepime: a single-center retrospective cohort study-Reference-Cited by-同舟云学术

Higher incidence of acute kidney injury in patients treated with piperacillin/tazobactam than in patients treated with cefepime: a single-center retrospective cohort study

Published:2019-06-12 Issue:1 Volume:5 Page:
ISSN:2055-0294
Container-title:Journal of Pharmaceutical Health Care and Sciences
language:en
Short-container-title:J Pharm Health Care Sci

Author:

Kadomura Shota^ORCID,Takekuma Yoh,Sato Yuki,Sumi Masato,Kawamoto Kotaro,Itoh Tatsuya,Sugawara Mitsuru

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology (nursing)

Link

http://link.springer.com/content/pdf/10.1186/s40780-019-0142-6.pdf

Reference22 articles.

1. Burgess LD, Drew RH. Comparison of the incidence of vancomycin-induced nephrotoxicity in hospitalized patients with and without concomitant piperacillin-tazobactam. Pharmacotherapy. 2014;34(7):670–6.

2. Gomes DM, Smotherman C, Birch A, Dupree L, Della Vecchia BJ, Kraemer DF, et al. Comparison of acute kidney injury during treatment with vancomycin in combination with piperacillin-tazobactam or cefepime. Pharmacotherapy. 2014;34(7):662–9.

3. Karino F, Nishimura N, Ishihara N, Moriyama H, Miura K, Hamaguchi S, et al. Nephrotoxicity Induced by Piperacillin – Tazobactam in Late Elderly Japanese Patients with Nursing and Healthcare Associated Pneumonia. Biol Pharm Bull. 2014;37(12):1971–6.

4. Mac K, Chavada R, Paull S, Howlin K, Wong J. Cefepime induced acute interstitial nephritis - A case report. BMC Nephrol. 2015;16(1):1–6.

5. Nephrology JS of. Evidence-based Practice Guideline for the Treatment of CKD. Clin Exp Nephrol. 2009;13(6):537–66.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute Kidney Injury After the Concurrent Use of Checkpoint Inhibitors and Proton Pump Inhibitors;Annals of Internal Medicine: Clinical Cases;2024-02-01

2. Drug Utilization Evaluation and Impact of Pharmacist Interventions on Optimization of Piperacillin/Tazobactam Use: A Retrospective Analysis and Prospective Audit;Antibiotics;2023-07-15

3. Underdiagnosed CKD in Geriatric Trauma Patients and Potent Prevention of Renal Impairment from Polypharmacy Risks through Individual Pharmacotherapy Management (IPM-III);Journal of Clinical Medicine;2023-07-07

4. Protocol and statistical analysis plan for the Antibiotic Choice On ReNal outcomes (ACORN) randomised clinical trial;BMJ Open;2023-03

5. Risk of Acute Kidney Injury and Fracture-Related Infection After Antibiotic Prophylaxis With Piperacillin-Tazobactam in Open Fractures;Journal of Orthopaedic Trauma;2023-02